by Scott Larrivee | Oct 7, 2024 | News
VALENCIA, Calif. – Oct. 7, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced it will speak at three industry conferences in October 2024. Oppenheimer 2nd Annual Targeted Radiopharmaceutical Therapies in...
by Scott Larrivee | Oct 3, 2024 | News
VALENCIA, Calif. – Oct. 3, 2024 – Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced the addition of two executives to support its business commercialization and the availability of non-carrier-added lutetium-177...
by Scott Larrivee | Oct 1, 2024 | News
Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial uses VALENCIA, Calif. – Oct. 1, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced a Series C...
by Scott Larrivee | Sep 27, 2024 | Blog
September 2024 – Insights Care recently interviewed Nusano CEO Chris Lowe for its “5 Most Trusted Radiopharmaceutical Companies to Watch” edition. Lowe discussed the urgent need for new medical radioisotope supplies, how Nusano will be part of the...
by Scott Larrivee | Sep 27, 2024 | Blog, Utah
Nusano is featured in the 2024 edition of Biosphere magazine entitled “Profiles in Innovation.” Published by BioUtah, the publication highlights advancements occurring throughout Utah’s life sciences industry. In the article, Nusano’s CEO Chris...
